Boaz Mendzelevski

861 total citations
19 papers, 617 citations indexed

About

Boaz Mendzelevski is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Boaz Mendzelevski has authored 19 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 5 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Boaz Mendzelevski's work include Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Structural Anomalies and Repair (3 papers) and ECG Monitoring and Analysis (2 papers). Boaz Mendzelevski is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Structural Anomalies and Repair (3 papers) and ECG Monitoring and Analysis (2 papers). Boaz Mendzelevski collaborates with scholars based in United States, United Kingdom and Israel. Boaz Mendzelevski's co-authors include D. O. Chanter, Jay W. Mason, Daniel B. Goodman, Thomas E. Moon, Dani Bitran, Michael Ilan, Yaron Almagor, Marc Klutstein, Dan Tzivoni and Jannie Ausma and has published in prestigious journals such as Neurology, American Heart Journal and British Journal of Clinical Pharmacology.

In The Last Decade

Boaz Mendzelevski

19 papers receiving 585 citations

Peers

Boaz Mendzelevski

CCM

SURGE

GASTR

RNMI

Woong Choi South Korea

Uwe Primeßnig Germany

Lang Lin China

Seiji Itoh Japan

S Tanaka Japan

Jui‐Shan Lin Taiwan

Jakob Wollborn Germany

Christian Doutremépuich France

John Burkhardt United States

Jae Moon Choi South Korea

Woong Choi South Korea

Boaz Mendzelevski

163 ×0.4

CCM

201 ×1.4

SURGE

123 ×0.9

36 ×0.7

GASTR

44 ×1.0

RNMI

Citations per year, relative to Boaz Mendzelevski Boaz Mendzelevski (= 1×) peers Woong Choi

Countries citing papers authored by Boaz Mendzelevski

Since Specialization

Citations

This map shows the geographic impact of Boaz Mendzelevski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boaz Mendzelevski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boaz Mendzelevski more than expected).

Fields of papers citing papers by Boaz Mendzelevski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boaz Mendzelevski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boaz Mendzelevski. The network helps show where Boaz Mendzelevski may publish in the future.

Co-authorship network of co-authors of Boaz Mendzelevski

This figure shows the co-authorship network connecting the top 25 collaborators of Boaz Mendzelevski. A scholar is included among the top collaborators of Boaz Mendzelevski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boaz Mendzelevski. Boaz Mendzelevski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Mendzelevski, Boaz, et al.. (2021). Comparing the consistency of electrocardiogram interval measurements by resting ECG versus 12‐lead Holter. Annals of Noninvasive Electrocardiology. 26(5). e12851–e12851. 4 indexed citations

Mendzelevski, Boaz, Georg Ferber, Filip Jankú, et al.. (2018). Effect of ulixertinib, a novel ERK1/2 inhibitor, on the QT/QTc interval in patients with advanced solid tumor malignancies. Cancer Chemotherapy and Pharmacology. 81(6). 1129–1141. 19 indexed citations

Tran, Jonathan Q., Jeffrey Hartung, Allan Olson, et al.. (2017). Cardiac Safety of Ozanimod, a Novel Sphingosine‐1‐Phosphate Receptor Modulator: Results of a Thorough QT/QTc Study. Clinical Pharmacology in Drug Development. 7(3). 263–276. 47 indexed citations

Jung, Jin Ah, Tomoe Fujita, Hideki Amano, et al.. (2016). Population Pharmacokinetic–Pharmacodynamic Analysis to Compare the Effect of Moxifloxacin on QT Interval Prolongation Between Healthy Korean and Japanese Subjects. Clinical Therapeutics. 38(12). 2610–2621. 7 indexed citations

Cohen‐Barak, Orit, et al.. (2015). Safety, pharmacokinetic and pharmacodynamic properties of TV-1106, a long-acting GH treatment for GH deficiency. European Journal of Endocrinology. 173(5). 541–551. 15 indexed citations

Chen, Qian, Yanmei Liu, Yun Liu, et al.. (2015). Orally administered moxifloxacin prolongs QTc in healthy Chinese volunteers: a randomized, single-blind, crossover study. Acta Pharmacologica Sinica. 36(4). 448–453. 15 indexed citations

Cohen‐Barak, Orit, Aviva Gross, Merav Bassan, et al.. (2014). Safety, pharmacokinetics, and pharmacodynamics of TV‐1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects. The Journal of Clinical Pharmacology. 55(5). 573–583. 48 indexed citations

Hartung, Jeffrey, Allan Olson, Robert Peach, et al.. (2014). Absence Of A Relevant Effect On Cardiac Repolarization In A QT/QTc (TQT) Study of RPC1063, A Novel, Selective S1P1 Receptor Agonist, In Healthy Adult Volunteers (P2.229). Neurology. 82(10_supplement). 1 indexed citations

Geiger, Mary Jane, Cyrus R. Mehta, J. Rick Turner, et al.. (2014). Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 Diabetes. Therapeutic Innovation & Regulatory Science. 49(1). 50–64. 14 indexed citations

10.

Mendzelevski, Boaz, et al.. (2014). Cardiac safety of rasagiline, a selective monoamine oxidase type B inhibitor for the treatment of Parkinsonâs disease: a thorough QT/QTc study. International Journal of Clinical Pharmacology and Therapeutics. 52(3). 192–201. 7 indexed citations

11.

Sager, Philip T., J. Rick Turner, Gary A. Gintant, et al.. (2013). Assessment of drug-induced increases in blood pressure during drug development: Report from the Cardiac Safety Research Consortium. American Heart Journal. 165(4). 477–488. 18 indexed citations

12.

Braddock, Martin, et al.. (2013). Cardiovascular safety and hemodynamic considerations in oncology drug development – webinar highlights October 10th 2012. Expert Opinion on Drug Safety. 12(5). 783–791. 2 indexed citations

13.

Mendzelevski, Boaz, Jannie Ausma, D. O. Chanter, et al.. (2011). Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double‐blind, placebo‐ and positive‐controlled thorough QT study. British Journal of Clinical Pharmacology. 73(2). 203–209. 56 indexed citations

14.

Mason, Jay W., et al.. (2007). Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. Journal of Electrocardiology. 40(3). 228–234.e8. 253 indexed citations

15.

Mendzelevski, Boaz & Ulrich Sigwart. (1998). Management of aortic dissection complicating coronary intervention. Catheterization and Cardiovascular Diagnosis. 43(4). 491–491a. 1 indexed citations

16.

Mendzelevski, Boaz & Ulrich Sigwart. (1997). Rupture of coronary artery and cardiac tamponade complicating Wallstent implantation. Catheterization and Cardiovascular Diagnosis. 40(4). 368–371. 3 indexed citations

17.

Klutstein, Marc, Dan Tzivoni, Dani Bitran, et al.. (1997). Treatment of spontaneous coronary artery dissection: Report of three cases. Catheterization and Cardiovascular Diagnosis. 40(4). 372–376. 70 indexed citations

18.

Mendzelevski, Boaz, et al.. (1996). Dobutamine-induced ST segment elevation and ventricular fibrillation with nonsignificant coronary artery disease. American Heart Journal. 132(5). 1058–1060. 12 indexed citations

19.

Fink, Daniel, et al.. (1996). Coronary artery bypass surgery during pregnancy. European Journal of Cardio-Thoracic Surgery. 10(10). 925–926. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact